Short-Term Effectiveness of Oral Nirmatrelvir/Ritonavir Against the SARS-CoV-2 Omicron Variant and Culture-Positive Viral Shedding.

Eunyoung Lee Sehee Park Jae Phil Choi Min-Kyoung Kim Eun Mi Yang Sin Young Ham Seungjae Lee Bora Lee Jeong-Sun Yang Byoung Kwon Park Da Sol Kim So-Young Lee Joo-Yeon Lee Hee-Chang Jang Jae-Hyun Jeon Wan Beom Park

Published in: Journal of Korean medical science (2023)

Nirmatrelvir/ritonavir against the omicron was safe and resulted in negative viral culture conversion after Day 5 of treatment with better symptomatic resolution.

Keyphrases

sars cov
respiratory syndrome coronavirus
randomized controlled trial
antiretroviral therapy
systematic review
single molecule